Efegatran
- Level
- Commodity
- Parent
- 51131600
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51131636This classification denotes a protease inhibitor and anticoagulant agent with the molecular formula C21H32N6O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, VT0VK2474K chemically known as l-prolinamide, n-methyl-d-phenylalanyl-n-(4-((aminoiminomethyl)amino)-1-formylbutyl)-, (s)- but generally known as efegatran, which bears US NIH Compound Identifier 122267. European Medicines Agency schedules Efegatran in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06464MIG. The term EFEGATRAN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 9, no. 3, 1995, list 35). Most nations schedule efegatran under HS 29339990 and SITC 51577. As of Q4 2014, EFEGATRAN remains the US FDA Preferred Term for this commodity. Efegatran bears US NLM identifiers UMLS ID C0286590 and NCI Concept Code C72749. SMILES: CNC(CC1=CC=CC=C1)C(=O)N2CCCC2C(=O)NC(CCCN=C(N)N)C=O.
Same parent
Under 51131600 · 61Activities that produce or sell this
KBLI · 8Inherited from family 51130000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.